Foreign-Trade Zone 93-Raleigh/Durham, North Carolina, Authorization of Production Activity, GlaxoSmithKline, PLC (Pharmaceutical Products), Zebulon, North Carolina, 16768 [2014-06707]
Download as PDF
16768
Federal Register / Vol. 79, No. 58 / Wednesday, March 26, 2014 / Notices
Notice and Opportunity for
Public Comment.
ACTION:
DEPARTMENT OF COMMERCE
Economic Development Administration
Pursuant to Section 251 of the Trade
Act 1974, as amended (19 U.S.C. 2341
et seq.), the Economic Development
Administration (EDA) has received
petitions for certification of eligibility to
apply for Trade Adjustment Assistance
from the firms listed below.
Notice of Petitions by Firms for
Determination of Eligibility To Apply
for Trade Adjustment Assistance
Economic Development
Administration, Department of
Commerce.
AGENCY:
Accordingly, EDA has initiated
investigations to determine whether
increased imports into the United States
of articles like or directly competitive
with those produced by each of these
firms contributed importantly to the
total or partial separation of the firm’s
workers, or threat thereof, and to a
decrease in sales or production of each
petitioning firm.
LIST OF PETITIONS RECEIVED BY EDA FOR CERTIFICATION ELIGIBILITY TO APPLY FOR TRADE ADJUSTMENT ASSISTANCE
[03/14/2014 through 03/20/2014]
Date accepted for
investigation
Firm name
Firm address
Cape Pond Ice Company, Inc ...............
104 Commercial Street, PO Box 440,
Gloucester, MA 01931.
384 Beinoris Drive, Wood Dale, IL
60190.
6425 Cunningham Rd, Houston, TX
77041.
Frey & Weiss Precision Machining, Inc
GaUS Anodes International, LLC ..........
Any party having a substantial
interest in these proceedings may
request a public hearing on the matter.
A written request for a hearing must be
submitted to the Trade Adjustment
Assistance for Firms Division, Room
71030, Economic Development
Administration, U.S. Department of
Commerce, Washington, DC 20230, no
later than ten (10) calendar days
following publication of this notice.
Please follow the requirements set
forth in EDA’s regulations at 13 CFR
315.9 for procedures to request a public
hearing. The Catalog of Federal
Domestic Assistance official number
and title for the program under which
these petitions are submitted is 11.313,
Trade Adjustment Assistance for Firms.
FTZ 93—Site 6, in Zebulon, North
Carolina.
The notification was processed in
accordance with the regulations of the
FTZ Board (15 CFR part 400), including
notice in the Federal Register inviting
public comment (78 FR 70531–70532,
11–26–2013). The FTZ Board has
determined that no further review of the
activity is warranted at this time. The
production activity described in the
notification is authorized, subject to the
FTZ Act and the Board’s regulations,
including Section 400.14.
Dated: March 18, 2014.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2014–06707 Filed 3–25–14; 8:45 am]
Bureau of Industry and Security
BILLING CODE 3510–WH–P
Ernest Chornoletskyy, a/k/a Erik
Chornoletskyy; Order Denying Export
Privileges
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B–98–2013]
sroberts on DSK5SPTVN1PROD with NOTICES
3/21/2014
DEPARTMENT OF COMMERCE
[FR Doc. 2014–06634 Filed 3–25–14; 8:45 am]
Foreign-Trade Zone 93—Raleigh/
Durham, North Carolina, Authorization
of Production Activity,
GlaxoSmithKline, PLC (Pharmaceutical
Products), Zebulon, North Carolina
On November 18, 2013, the Triangle
J Council of Governments, grantee of
FTZ 93, submitted a notification of
proposed production activity to the
Foreign-Trade Zones (FTZ) Board on
behalf of GlaxoSmithKline, PLC, within
17:43 Mar 25, 2014
3/18/2014
BILLING CODE 3510–DS–P
Dated: March 20, 2014.
Michael DeVillo,
Eligibility Examiner.
VerDate Mar<15>2010
3/18/2014
Jkt 232001
In the Matter of:
Ernest Chornoletskyy a/k/a Erik
Chornoletskyy currently incarcerated at:
Inmate Number—43799–424, CI NE Ohio
Corr Ctr, Correctional Institution, 2240
Hubbard Rd., Youngstown, OH 44501
and with an address at:
Ernest Chornoletskyy, a/k/a Erik
Chornoletskyy, 4310 Marmora Ave. N,
Chicago, IL 60634.
Order Denying Export Privileges
On August 21, 2013, in the U.S.
District Court, Eastern District of
Pennsylvania, Ernest Chornoletskyy,
PO 00000
Frm 00015
Fmt 4703
Sfmt 4703
Product(s)
The firm produces block ice and fragmentary ice.
The firm manufactures precision machined metal parts.
The firm manufacturers cast aluminum
sacrificial anodes for corrosive environments.
a/k/a Erik Chornoletskyy
(‘‘Chornoletskyy’’), was convicted of
violating the International Emergency
Economic Powers Act (50 U.S.C. 1701,
et seq. (2006 & Supp. IV 2010))
(‘‘IEEPA’’). Specifically, Chornoletskyy
conspired to willfully export from the
United States to Belarus exportcontrolled items, including L–3 x 200xp
Handheld Thermal Imaging Cameras,
without first obtaining from the United
States Department of Commerce a
license or written authorization.
Chornoletskyy was sentenced to 15
months of imprisonment, three years of
supervised release, a $200 assessment
and a $3,000 fine. Chornoletskyy is also
listed on the U.S. Department of State
Debarred List.
Section 766.25 of the Export
Administration Regulations (‘‘EAR’’ or
‘‘Regulations’’) 1 provides, in pertinent
part, that ‘‘[t]he Director of the Office of
Exporter Services, in consultation with
the Director of the Office of Export
Enforcement, may deny the export
privileges of any person who has been
convicted of a violation of the Export
Administration Act (‘‘EAA’’), the EAR,
or any order, license or authorization
issued thereunder; any regulation,
1 The Regulations are currently codified in the
Code of Federal Regulations at 15 CFR parts 730–
774 (2013). The Regulations issued pursuant to the
Export Administration Act (50 U.S.C. app. §§ 2401–
2420 (2000)) (‘‘EAA’’). Since August 21, 2001, the
EAA has been in lapse and the President, through
Executive Order 13222 of August 17, 2001 (3 CFR,
2001 Comp. 783 (2002)), which has been extended
by successive Presidential Notices, the most recent
being that of August 8, 2013 (78 FR 49107 (August
12, 2013)), has continued the Regulations in effect
under the International Emergency Economic
Powers Act (50 U.S.C. 1701, et seq. (2006 & Supp.
IV 2010)).
E:\FR\FM\26MRN1.SGM
26MRN1
Agencies
[Federal Register Volume 79, Number 58 (Wednesday, March 26, 2014)]
[Notices]
[Page 16768]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-06707]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-98-2013]
Foreign-Trade Zone 93--Raleigh/Durham, North Carolina,
Authorization of Production Activity, GlaxoSmithKline, PLC
(Pharmaceutical Products), Zebulon, North Carolina
On November 18, 2013, the Triangle J Council of Governments,
grantee of FTZ 93, submitted a notification of proposed production
activity to the Foreign-Trade Zones (FTZ) Board on behalf of
GlaxoSmithKline, PLC, within FTZ 93--Site 6, in Zebulon, North
Carolina.
The notification was processed in accordance with the regulations
of the FTZ Board (15 CFR part 400), including notice in the Federal
Register inviting public comment (78 FR 70531-70532, 11-26-2013). The
FTZ Board has determined that no further review of the activity is
warranted at this time. The production activity described in the
notification is authorized, subject to the FTZ Act and the Board's
regulations, including Section 400.14.
Dated: March 18, 2014.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2014-06707 Filed 3-25-14; 8:45 am]
BILLING CODE 3510-DS-P